Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Rises By 275.0%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 275.0% from the December 31st total of 400 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is presently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.8 %

Shares of First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.23 during trading hours on Tuesday, reaching $27.72. 1,029 shares of the company’s stock were exchanged, compared to its average volume of 2,472. The company has a 50 day moving average of $27.46 and a two-hundred day moving average of $28.24. The stock has a market cap of $15.25 million, a P/E ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $25.73 and a fifty-two week high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were paid a $0.1304 dividend. The ex-dividend date was Friday, December 13th. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.